Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study-Reference-Cited by-同舟云学术

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

Published:2010-06 Issue:6 Volume:11 Page:521-529
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cappuzzo Federico,Ciuleanu Tudor,Stelmakh Lilia,Cicenas Saulius,Szczésna Aleksandra,Juhász Erzsébet,Esteban Emilio,Molinier Olivier,Brugger Wolfram,Melezínek Ivan,Klingelschmitt Gaëlle,Klughammer Barbara,Giaccone Giuseppe

Publisher

Elsevier BV

Subject

Oncology

Reference27 articles.

1. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions;Ramalingam;Oncologist,2008

2. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil;Reck;J Clin Oncol,2009

3. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial;Brodowicz;Lung Cancer,2006

4. Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18;Leighl;J Clin Oncol,2005

5. Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003;Williamson;J Clin Oncol,2005

Cited by 1092 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and bioevaluation of dual EGFR-PI3Kα inhibitors for potential treatment of NSCLC;Bioorganic Chemistry;2024-10

2. Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial;Journal of Clinical Oncology;2024-08-05

3. Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials;Medicine;2024-07-05

4. Efficacy and safety of EGFR-TKIs for non-small cell lung cancer: A meta-analysis of randomized controlled clinical trials;Medicine;2024-06-07

5. Adverse Event Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer: An Updated Meta-analysis;Targeted Oncology;2024-06-01